After 24 years in London, the European Medicines Agency (EMA) on Friday has officially departed and is on its way to Amsterdam following a Brexit relocation vote in November 2017.
EMA’s permanent Amsterdam headquarters, a tailor-made building in the Zuidas business district, are planned for completion next November. On a temporary basis, the Dutch government has granted EMA the Spark building in the Sloterdijk area of Amsterdam until the permanent building is completed.
The move to Amsterdam also comes with a time zone switch, which could have an impact on submissions and deadlines.
EMA said that during its period of “reduced virtual presence,” from 4 March to 8 March, the agency’s working hours will continue to follow Greenwich Mean Time (GMT)…